Small Business Transition Grant for New Entrepreneurs (Parent R41/R42 Clinical Trial Optional)
This is a forecasted opportunity — a pre-announcement that isn’t open for applications yet. Dates and details may change before it posts.
This is a forecasted NIH Small Business Transition Grant for New Entrepreneurs (Parent R41/R42 STTR, clinical trial optional). STTR awards are restricted to U.S. small businesses (for-profit) partn…
- Deadline
- Not specified
- Posted
- May 27, 2026
- Award amount
- Amount not specified
In plain English
This is a forecasted NIH Small Business Transition Grant for New Entrepreneurs (Parent R41/R42 STTR, clinical trial optional). STTR awards are restricted to U.S. small businesses (for-profit) partnering with a research institution, and this notice targets new entrepreneurs transitioning into the small-business research space. Specific funding amounts and deadlines are not yet posted; note STTR programs carry U.S. small-business ownership and size requirements plus a required research-institution partner.
AI-generated summary to help you decide quickly — verify the official eligibility rules before applying.
Let AI draft your application
Your first draft is free: a narrative and budget outline tailored to this grant, emailed to you. Drafts are written in a nightly batch, so it arrives by email later — not instantly on this page.
Application Kit — $49 one-time
Winner intelligence + a first-draft narrative grounded in applications that actually won. One payment, no subscription.
Get the Application Kit →Related grants
Other open grants from National Institutes of Health — soonest deadline first.
Amyotrophic Lateral Sclerosis (ALS) Intermediate Patient Population Expanded Access (U01 Clinical Trial Required)
National Institutes of Health · Amount varies · Due Nov 10, 2026
Optimal Treatment Strategies for use of Anti-Obesity Medications (AOMs) in Children and Adolescents Research Coordinating Center (U24 Clinical Trial Not Allowed)
National Institutes of Health · Amount varies · Due in 3 days
Assay Validation of High Quality Markers for Clinical Studies in Cancer (UH2/UH3 Clinical Trial Not Allowed)
National Institutes of Health · Amount varies · Due in 8 days
Assay Validation of High Quality Markers for Clinical Studies in Cancer (UH3 Clinical Trials Not Allowed)
National Institutes of Health · Up to $250K · Due in 8 days
Revision Applications for Validation of Biomarker Assays Developed Through NIH-Supported Research Grants (R01 Clinical Trial Not Allowed)
National Institutes of Health · Amount varies · Due in 8 days
NCI Pathway to Independence Award for Early-Stage Postdoctoral Researchers (K99/R00 - Independent Clinical Trial Not Allowed)
National Institutes of Health · Amount varies · Due in 8 days
Also listed under National Institutes of Health.
Source: public records via Grants.gov. UseGrants is an independent aggregator, not affiliated with any funding agency. Always confirm details on the official listing before applying.